1-9 of 9
paralytic ileus
Close
Sort by
Journal Articles

The Use of Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Gastrointestinal Graft-Versus-Host-Disease in Adults and Children

Sadeghi Behnam, PhD MD, Remberger Mats, PhD, Per Frisk, MD PhD, Britt-Marie Frost, MD PhD, Olle Ringden, Professor, Britt Gustafsson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4456.
https://doi.org/10.1182/blood-2019-122674
Published: 2019
Journal Articles

A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma

Henrik Gregersen, MD, Niels Abildgaard, MD, Trung Hieu Do, MD, Ida Bruun Kristensen, MD, Ulf Christian Frølund, MD, Niels Frost Andersen, MD, Lene Kongsgaard Nielsen, MD, Christen Lykkegaard Andersen, MD, Tobias Wirenfeldt Klausen, M.S., Annette Juul Vangsted, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3129.
https://doi.org/10.1182/blood.V130.Suppl_1.3129.3129
Published: 2017
Journal Articles

Voriconazole Increase the Risk of PN in Multiple Myeloma Patients Treated with Bortezomib-Based Chemotherapy

Yan Xu, MDPhD, Shuhui Deng, MD, Gang An, MDPhD, Zengjun Li, Sr., Xiaoqi Qin, MD, Weiwei Sui, MD, Xiaoyan Feng, Dehui Zou, Lugui Qiu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5394.
https://doi.org/10.1182/blood.V126.23.5394.5394
Published: 2015
Journal Articles

Gemcitabine, Vinorelbine and Dexamethasone (GVDexa) As Second-Line Salvage Regimen in Relapsed and Refractory Hodgkin's Lymphoma

Anjana Joel, MD, Prasanth Ganesan, MDDM, Tenali Gnana Sagar, MDDM, Krishnarathnam Kannan, MDDM, Trivadi Ganesan, MD, Venkatraman Radhakrishnan, MDDM, Rejiv Rajendranath, MDDM, Shirley Sundersingh, MD, Vandana Vikas, MD
Journal: Blood
Blood (2015) 126 (23): 3948.
https://doi.org/10.1182/blood.V126.23.3948.3948
Published: 2015
Journal Articles

Final Results of a Phase II Trial of Belinostat (PXD101) in Patients with Recurrent or Refractory Peripheral or Cutaneous T-Cell Lymphoma.

Brad Pohlman, Ranjana Advani, MD, Madeleine Duvic, MD, Kenneth B. Hymes, MD, Tanin Intragumtornchai, MD, Arnuparp Lekhakula, Ofer Shpilberg, Adam Lerner, MD, Dina Ben-Yehuda, Marie beylot-Barry, Uwe Hillen, Jan Fagerberg, Francine M Foss
Journal: Blood
Blood (2009) 114 (22): 920.
https://doi.org/10.1182/blood.V114.22.920.920
Published: 2009
Journal Articles

Response to Bortezomib Based Induction Therapy in Newly Diagnosed Light Chain (AL) Amyloidosis.

Veerpal Singh, MD, Ayman Saad, MD, Jeanne Palmer, MD, Jasleen K Randhawa, MD, Parameswaran N. Hari, MD, MS
Journal: Blood
Blood (2009) 114 (22): 1867.
https://doi.org/10.1182/blood.V114.22.1867.1867
Published: 2009
Journal Articles

Belinostat (PXD101) in Patients with Recurrent or Refractory Peripheral or Cutaneous T-Cell Lymphoma: Results of a Phase II Study.

Ranjana Advani, MD, K. Hymes, MD, B. Pohlman, MD, E. Jacobsen, MD, J. McDonnell, MD, R. Belt, MD, A. Lerner, MD, Y. Kim, MD, R. Mundis, MD, T. Mansfield, PhD, P. Buhl-Jensen, MD, C.E. Ooi, PhD, M. Duvic, MD, F. Foss, MD
Journal: Blood
Blood (2007) 110 (11): 3453.
https://doi.org/10.1182/blood.V110.11.3453.3453
Published: 2007
Journal Articles

Itraconazole-Enhanced Vindesine Neurotoxicity in Adult Acute Lymphoblastic Leukaemia.

Suning Chen, PhD, De Pei Wu, PhD, Aining Sun, Huiying Qiu, ph.d., Zhengming Jin
Journal: Blood
Blood (2006) 108 (11): 4538.
https://doi.org/10.1182/blood.V108.11.4538.4538
Published: 2006
Journal Articles

Bortezomib Is Not Active in Patients with Relapsed Hodgkin’s Lymphoma: Results of a Prematurely Closed Phase II Study.

Sven Trelle, Orhan Sezer, Ralph Naumann, Mathias Rummel, Ulrich Keller, Maike Nickelsen, Andreas Engert, Peter Borchmann
Journal: Blood
Blood (2006) 108 (11): 2477.
https://doi.org/10.1182/blood.V108.11.2477.2477
Published: 2006